Meloxicam and Type 2 diabetes - a phase IV clinical study of FDA data

Summary:

Type 2 diabetes is found among people who take Meloxicam, especially for people who are female, 40-49 old, have been taking the drug for 2 - 5 years.

The phase IV clinical study analyzes which people take Meloxicam and have Type 2 diabetes. It is created by eHealthMe based on reports of 55,060 people who have side effects when taking Meloxicam from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 24, 2023

55,060 people reported to have side effects when taking Meloxicam.
Among them, 217 people (0.39%) have Type 2 diabetes.

What is Meloxicam?

Meloxicam has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 58,112 Meloxicam users for its effectiveness, alternative drugs and more.

What is Type 2 diabetes?

Type 2 diabetes is found to be associated with 2,606 drugs and 2,135 conditions by eHealthMe.

Number of Meloxicam and Type 2 diabetes reports submitted per year:

* Approximation only. Some reports may have incomplete information.

Do you take Meloxicam and have Type 2 diabetes?

Check whether Type 2 diabetes is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Lai SW, Lin CL, Liao KF, "Association of Meloxicam Use with the Risk of Acute Pancreatitis: A Case–Control Study", Clinical drug investigation, 2015 Oct .

Related studies

How severe was Type 2 diabetes and when was it recovered:

Type 2 diabetes in Meloxicam

Expand to all the drugs that have ingredients of meloxicam:

Type 2 diabetes and drugs with ingredients of meloxicam (335 reports)

Alternative drugs to, pros and cons of Meloxicam:

Meloxicam (58,112 reports)

Common Meloxicam side effects:

Drug ineffective: 5,797 reports
Pain: 4,875 reports
Fatigue (feeling of tiredness): 4,602 reports
Joint pain: 4,093 reports
Headache (pain in head): 2,976 reports
Diarrhea: 2,894 reports
Chronic kidney disease: 2,865 reports

Browse all side effects of Meloxicam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Type 2 diabetes treatments and more:

Type 2 diabetes (344,796 reports)

COVID vaccines that are related to Type 2 diabetes:

Common drugs associated with Type 2 diabetes:

All the drugs that are associated with Type 2 diabetes:

Type 2 diabetes (2,606 drugs)

Common conditions associated with Type 2 diabetes:

High blood cholesterol: 10,207 reports
Depression: 3,626 reports
High blood pressure: 2,390 reports
Bipolar disorder: 2,243 reports
Rheumatoid arthritis: 2,099 reports

All the conditions that are associated with Type 2 diabetes:

Type 2 diabetes (2,135 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on meloxicam (the active ingredients of Meloxicam) and Meloxicam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.